CONMED Corporation Announces Third Quarter 2016 Financial Results

Go back to CONMED Corporation Announces Third Quarter 2016 Financial Results

Leerink Partners Cuts Price Target on Conmed (CNMD) to $43; Reiterates Market Perform

October 28, 2016 9:04 AM EDT

Leerink Partners maintained a Market Perform rating on CONMED (NASDAQ: CNMD), and cut the price target to $43.00 (from $47.00), following the company's 3Q earnings report. 3Q revenues of $185M beat $178M estimates, and organic growth of +0.8% beat +0.4% forecasts and marked an improvement vs. -1% in 2Q and -2% in 1Q. Airseal revenues... More

Conmed (CNMD) Tops Q3 EPS by 1c

October 27, 2016 5:19 PM EDT

Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.41, $0.01 better than the analyst estimate of $0.40. Revenue for the quarter came in at $184.8 million versus the consensus estimate of $180.13 million.

Conmed reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Conmed (CNMD) click here.

... More